Comparison of Volume Assist Control, Dual Mode and Airway Pressure Release Ventilation. (COMIX-R)

January 8, 2024 updated by: University Hospital, Angers

Comparison of Volume Assist Control, Dual Mode and Airway Pressure Release Ventilation: A Physiological Study

The aim of the COMIX-R study is to assess the short term physiological effects of 3 ventilation strategies for adult patients with ARDS admitted to intensive care unit

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France, 49100
        • University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years or older
  • Invasive mechanical ventilation on tracheal probe
  • Acute respiratory distress syndrome, as defined by Berlin conference consensus, during hospitalization in intensive care,
  • Recovery phase of acute respiratory distress syndrome: spontaneous ventilation representing from 20 to 30% of ventilation in APRV mode.
  • No severe acidosis (pH> 7.30)
  • Patient affiliated to or beneficiary of a health care plan
  • Express consent of the patient or his/her SDM

Exclusion Criteria:

  • Pneumothorax
  • Contraindication to the insertion of a nasogastric tube with an esophageal balloon
  • Contraindication to the use of Electrical impedance tomography (pacemaker)
  • Pregnancy, lactating or parturient woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dual Mode first
Four consecutive steps (45 min per step) in the following order: APRV (A), Dual Mode (B) , APRV (A) and VAC (C). (ABAC)
Patients are ventilated in randomised order with three different ventilation strategies: volume assist control (constant flow), Dual Mode or Airway Pressure Released Ventilation
Experimental: VAC fist
Four consecutive steps (45 min per step) in the following order: APRV (A), VAC (C) , APRV (A) and Dual Mode (B). (ACAB)
Patients are ventilated in randomised order with three different ventilation strategies: volume assist control (constant flow), Dual Mode or Airway Pressure Released Ventilation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of PaO2 (mmHg)
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
Arterial partial pressure of dioxygen Of note: As it is a physiological study, all the primary and secondary outcomes will be analyzed with the same importance.
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
-Respiratory rate variability
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
variability of rate (per minute)
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
-expiratory and inspiratory transpulmonary pressure
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
calculated with the esophageal pressure (cm H20)
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
-ventilation distribution in the lungs
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
Electrical impedance tomography (EIT) assess distribution of tidal volume and of end-expiratory lung volume (EELV) (delta Z, IU)
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
-other arterial parameters of hematosis
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
pH, PaO2, PaCo2 (mmHg)
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
-Work of breathing (WOB)
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
calculated with esophageal pressure (Kg/m)
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
-Pressure time product (PTP)
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
-Pressure time product (PTP) calculated with esophageal pressure (cmH2O.s.min-1)
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
-P0.1
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
pressure measured during the first 100 ms after an occlusion (cm H20)
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
-PEEPi
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
intrinsic positive end-expiratory pressure (cm H20)
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
MAP
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
mean arterial pressure
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
HR
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
heart rate (beats per minute)
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
-Respiratory comfort
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
visual analogic scale
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
-Patient-ventilator asynchronies
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
numbers of asynchronies analyzed on screen
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
-Tidal volume variability
Time Frame: 15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes
variability of Tidal volume (mL)
15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Francois BELONCLE, CCU-AH, Angers teatching hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 30, 2020

Primary Completion (Actual)

October 26, 2022

Study Completion (Actual)

October 26, 2022

Study Registration Dates

First Submitted

November 12, 2019

First Submitted That Met QC Criteria

December 11, 2019

First Posted (Actual)

December 12, 2019

Study Record Updates

Last Update Posted (Actual)

January 9, 2024

Last Update Submitted That Met QC Criteria

January 8, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 49RC19_0195

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ARDS

Clinical Trials on ventilation strategy

Subscribe